In-vivo models In-vivo models

ImmuneOncology



In-vivo models

‌Slicing complexity through integration of different models and advanced experimental tools

 

‌Biodistribution of human NK cells following injection into NSG mice
Fluorochrome labeled antibodies
Representative FACS dotplot is shown for the respective termination point

 

 

 

‌INTEGRATING EXPERIENCE WITH KNOLEDGE TO TAILORED AND EXECUTE THE BEST SOLUTION WITHIN THE ENMERGING FIELDS OF IMMUNO –ONCOLOGY AND CANCER TARGETED THERAPIES

 

For more information on how we can help you
move your drug or device along the development pathway.
Contact Us